116 related articles for article (PubMed ID: 2851301)
21. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
[TBL] [Abstract][Full Text] [Related]
22. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM
Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
[TBL] [Abstract][Full Text] [Related]
23. Solubilization of the calcium antagonist receptor from rat brain.
Curtis BM; Catterall WA
J Biol Chem; 1983 Jun; 258(12):7280-3. PubMed ID: 6305932
[TBL] [Abstract][Full Text] [Related]
24. Antihypertensive effects of intravenous administration of benidipine hydrochloride and some other calcium antagonists in conscious, spontaneously hypertensive rats.
Karasawa A; Kubo K; Oka T; Nakamizo N
Arzneimittelforschung; 1988 Nov; 38(11A):1691-4. PubMed ID: 3219141
[TBL] [Abstract][Full Text] [Related]
25. Investigations on the binding properties of the nootropic agent pyroglutamic acid.
Barone D; Spignoli G
Drugs Exp Clin Res; 1990; 16(2):85-99. PubMed ID: 1976055
[TBL] [Abstract][Full Text] [Related]
26. The receptor binding profile of the new antihypertensive agent nebivolol and its stereoisomers compared with various beta-adrenergic blockers.
Pauwels PJ; Gommeren W; Van Lommen G; Janssen PA; Leysen JE
Mol Pharmacol; 1988 Dec; 34(6):843-51. PubMed ID: 2462161
[TBL] [Abstract][Full Text] [Related]
27. Effects of dihydropyridine calcium channel blocking drugs on rat brain muscarinic and alpha-adrenergic receptors.
Thayer SA; Welcome M; Chhabra A; Fairhurst AS
Biochem Pharmacol; 1985 Jan; 34(2):175-80. PubMed ID: 2981533
[TBL] [Abstract][Full Text] [Related]
28. Antihypertensive effects of the new calcium antagonist benidipine hydrochloride in rats.
Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
Arzneimittelforschung; 1988 Nov; 38(11A):1684-90. PubMed ID: 3064752
[TBL] [Abstract][Full Text] [Related]
29. Effects of benidipine hydrochloride on atrioventricular conduction time and postural reflex in gallamine-immobilized cats.
Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
Arzneimittelforschung; 1988 Nov; 38(11A):1698-701. PubMed ID: 3219143
[TBL] [Abstract][Full Text] [Related]
30. Identification of calcium-channel receptors in intact animals.
Roeske WR; Lee HR; Yamamura HI; Schoemaker H
Adv Myocardiol; 1985; 6():71-82. PubMed ID: 2986265
[TBL] [Abstract][Full Text] [Related]
31. Potent enhancement of [3H]nitrendipine binding in rat cerebral cortical and cardiac homogenates: a putative mechanism for the action of MDL 12,330A.
Lee HR; Jaros JA; Roeske WR; Wiech NL; Ursillo R; Yamamura HI
J Pharmacol Exp Ther; 1985 Jun; 233(3):611-6. PubMed ID: 3159884
[TBL] [Abstract][Full Text] [Related]
32. Receptor binding profile of tibalosine, a new antihypertensive.
Chatelain P; Friedhoff AJ; Meller E; Mennini T; Gorissen H; Roba J
Arzneimittelforschung; 1984; 34(7):754-8. PubMed ID: 6093823
[TBL] [Abstract][Full Text] [Related]
33. Characteristics of the binding of [3H]nitrendipine to rabbit ventricular membranes: modification by other Ca++ channel antagonists and by the Ca++ channel agonist Bay K 8644.
Janis RA; Sarmiento JG; Maurer SC; Bolger GT; Triggle DJ
J Pharmacol Exp Ther; 1984 Oct; 231(1):8-15. PubMed ID: 6208356
[TBL] [Abstract][Full Text] [Related]
34. Histamine and growth: interaction of antiestrogen binding site ligands with a novel histamine site that may be associated with calcium channels.
Brandes LJ; Bogdanovic RP; Cawker MD; LaBella FS
Cancer Res; 1987 Aug; 47(15):4025-31. PubMed ID: 2886214
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.
Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T
J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127
[TBL] [Abstract][Full Text] [Related]
36. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle.
Bolger GT; Gengo P; Klockowski R; Luchowski E; Siegel H; Janis RA; Triggle AM; Triggle DJ
J Pharmacol Exp Ther; 1983 May; 225(2):291-309. PubMed ID: 6842393
[TBL] [Abstract][Full Text] [Related]
37. Binding of a calcium antagonist, [3H]nitrendipine, to high affinity sites in bovine aortic smooth muscle and canine cardiac membranes.
Williams LT; Tremble P
J Clin Invest; 1982 Jul; 70(1):209-12. PubMed ID: 6282938
[TBL] [Abstract][Full Text] [Related]
38. Beneficial effects of the new calcium antagonist benidipine hydrochloride on myocardial dysfunction following coronary occlusion and reperfusion in anesthetized dogs.
Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
Arzneimittelforschung; 1988 Nov; 38(11A):1717-21. PubMed ID: 3219147
[TBL] [Abstract][Full Text] [Related]
39. Temperature-dependent modulation of [3H]nitrendipine binding by the calcium channel antagonists verapamil and diltiazem in rat brain synaptosomes.
Boles RG; Yamamura HI; Schoemaker H; Roeske WR
J Pharmacol Exp Ther; 1984 May; 229(2):333-9. PubMed ID: 6716261
[TBL] [Abstract][Full Text] [Related]
40. Mitochondrial Ca2+ antagonist binding sites are associated with an inner mitochondrial membrane anion channel.
Zernig G; Graziadei I; Moshammer T; Zech C; Reider N; Glossmann H
Mol Pharmacol; 1990 Sep; 38(3):362-9. PubMed ID: 1698252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
